Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More

Merck & Co. is in advanced talks to acquire Seagen and is aiming to agree on a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that co...